Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.
Aging (Albany NY). 2020 Feb 24;12(4):3312-3339. doi: 10.18632/aging.102814. Epub 2020 Feb 24.
Aging (Albany NY). 2020.
PMID: 32091408
Free PMC article.